^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AMBLor®

Type:
Other Approval
Evidence

News

2ms
AMLo Biosciences Gets UKCA Mark for Melanoma Biomarker Test (Precision Medicine Online)
"AMLo Biosciences said Tuesday that it has received UK Conformity Assessed (UKCA) marking for its AMBLor test for identifying early-stage melanomas at low risk of progression.."
Approval
|
AMBLor®